Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months

Circulation

DOI: 10.1161/circulationaha.117.028303 OpenAlex

Authors 0

Author list not loaded yet.

Cited by 6 stored of 282

Hemocompatibility and Long‐Term Outcomes in H eart W are Versus H eart M ate II Versus H eart M ate 3: Multicenter Real‐World Cohort
2026 Artificial Organs article Engineering Mechanical Circulatory Support Devices Open access

0

citations
Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device’s patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC
2024 EP Europace article Engineering Mechanical Circulatory Support Devices Open access

24

citations
Hemocompatibility-related Adverse Events in Patients With Temporary Mechanical Circulatory Support: The Scoring Haemostasis Events and Assessment for Risk (SHEAR) Score
2024 Journal of Cardiothoracic and Vascular Anesthesia article Engineering Mechanical Circulatory Support Devices Open access

6

citations
Pressure-Dimension Index and Left Ventricular Sphericity Index Following HeartMate II and HeartMate 3 implantation
2024 ESC Heart Failure article Engineering Mechanical Circulatory Support Devices Open access

3

citations
High‐dose supplementation of selenium in left ventricular assist device implant surgery: A double‐blinded, randomized controlled pilot trial
2021 Journal of Parenteral and Enteral Nutrition article Engineering Mechanical Circulatory Support Devices Open access

15

citations
Telemedizinische postoperative Versorgung herzchirurgischer Patienten
2020 Springer eBooks book-chapter Medicine Telemedicine and Telehealth Implementation

0

citations

6 results

Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months

Authors 0

Cited by 6 stored of 282

References 0